The Fanconi Anemia/BRCA pathway: New faces in the crowd

Genes and Development

Volumn 19, Issue 24, 2005, Pages 2925-2940

  Kennedy, Richard D ^a   D'Andrea, Alan D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BRCA; Cancer; Chemotherapy; DNA cross links; DNA helicase; Fanconi anemia

Indexed keywords

BRCA2 PROTEIN; PROTEIN P53;

APOPTOSIS; CELL CYCLE REGULATION; CLINICAL FEATURE; DATA ANALYSIS; DNA CROSS LINKING; DNA DAMAGE; FANCONI ANEMIA; HOMOLOGOUS RECOMBINATION; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

CELL CYCLE; CHROMOSOMAL INSTABILITY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FANCONI ANEMIA; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINATION, GENETIC; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

EID: 29144506137     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1370505     Document Type: Review

References (135)

1. Abraham, J., Lemmers, B., Hande, M.P., Moynahan, M.E., Chahwan, C., Ciccia, A., Essers, J., Hanada, K., Chahwan, R., Khaw, A.K., et al. 2003. Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells. EMBO J. 22: 6137-6147.
2. Akkari, Y.M., Bateman, R.L., Reifsteck, C.A., D'Andrea, A.D., Olson, S.B., and Grompe, M. 2001. The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. Mol. Genet. Metab. 74: 403-412.
3. Alter, B.P. 1996. Fanconi's anemia and malignancies. [Review]. Am. J. Hematol. 53: 99-110.
4. _. 2003. Cancer in Fanconi anemia, 1927-2001. Cancer 97: 425-440.
5. Alter, B.P., Greene, M.H., Velazquez, I., and Rosenberg, P.S. 2003. Cancer in Fanconi anemia. Blood 101: 2072.
6. Amerik, A.Y. and Hochstrasser, M. 2004. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta. 1695: 189-207.
7. Andreassen, P.R., D'Andrea, A.D., and Taniguchi, T. 2004. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes & Dev. 18: 1958-1963.
8. Auerbach, A.D. 1988. A test for Fanconi's anemia [letter]. Blood 72: 366-367.
9. Bagby Jr., G.C. 2003. Genetic basis of Fanconi anemia. Curr. Opin. Hematol. 10: 68-76.
10. Bartek, J., Lukas, C., and Lukas, J. 2004. Checking on DNA damage in S phase. Nat. Rev. Mol. Cell. Biol. 5: 792-804.
11. Bridge, W.L., Vandenberg, C.J., Franklin, R.J., and Hiom, K. 2005. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat. Genet. 37: 953-957.
12. Brosh Jr., R.M., Li, J.L., Kenny, M.K., Karow, J.K., Cooper, M.P., Kureekattil, R.P., Hickson, I.D., and Bohr, V.A. 2000. Replication protein A physically interacts with the Bloom's syndrome protein and stimulates its helicase activity. J. Biol. Chem. 275: 23500-23508.
13. Brummelkamp, T.R. and Bernards, R. 2003. New tools for functional mammalian cancer genetics. Nat. Rev. Cancer 3: 781-789.
14. Bryant, H.E., Schultz, N., Thomas, H.D., Parker, K.M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N.J., and Helleday, T. 2005. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434: 913-917.
15. Cantor, S.B., Bell, D.W., Ganesan, S., Kass, E.M., Drapkin, R., Grossman, S., Wahrer, D.C., Sgroi, D.C., Lane, W.S., Haber, D.A., et al. 2001. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105: 149-160.
16. Cantor, S., Drapkin, R., Zhang, F., Lin, Y., Han, J., Pamidi, S., and Livingston, D.M. 2004. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc. Natl. Acad. Sci. 101: 2357-2362.
17. Carreau, M., Alon, N., Bosnoyan-Collins, L., Joenje, H., and Buchwald, M. 1999. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mutat. Res. 435: 103-109.
18. Cass, I., Baldwin, R.L., Varkey, T., Moslehi, R., Narod, S.A., and Karlan, B.Y. 2003. Improved survival in women with BRCA-associated ovarian carcinoma. Cancer 97: 2187-2195.
19. Centurion, S.A., Kuo, H.R., and Lambert, W.C. 2000. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp. Cell. Res. 260: 216-221.
20. Chan, J.Y., Becker, F.F., German, J., and Ray, J.H. 1987. Altered DNA ligase I activity in Bloom's syndrome cells. Nature 325: 357-359.
21. Chappuis, P.O., Goffin, J., Wong, N., Perret, C., Ghadirian, P., Tonin, P.N., and Foulkes, W.D. 2002. A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer. J. Med. Genet. 39: 608-610.
22. Condie, A., Powles, R.L., Hudson, C.D., Shepherd, V., Bevan, S., Yuille, M.R., and Houlston, R.S. 2002. Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia. Leuk. Lymphoma 43: 1849-1853.
23. Couch, F.J., Johnson, M.R., Rabe, K., Boardman, L., McWilliams, R., de Andrade, M., and Petersen, G. 2005. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer. Cancer Res. 65: 383-386.
24. D'Andrea, A.D. and Grompe, M. 2003. The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer 3: 23-34.
25. D'Andrea, A. and Pellman, D. 1998. Deubiquitinating enzymes: A new class of biological regulators. Crit. Rev. Biochem. Mol. Biol. 33: 337-352.
26. de Winter, J.P., Waisfisz, Q., Rooimans, M.A., van Berkel, C.G., Bosnoyan-Collins, L., Alon, N., Carreau, M., Bender, O., Demuth, I., Schindler, D., et al. 1998. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat. Genet. 20: 281-283.
27. de Winter, J.P., Leveille, F., van Berkel, C.G., Rooimans, M.A., van Der Weel, L., Steltenpool, J., Demuth, I., Morgan, N.V., Alon, N., Bosnoyan-Collins, L., et al. 2000a. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67: 1306-1308.
28. de Winter, J.P., Rooimans, M.A., van Der Weel, L., van Berkel, C.G., Alon, N., Bosnoyan-Collins, L., de Groot, J., Zhi, Y., Waisfisz, Q., Pronk, J.C., et al. 2000b. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat. Genet. 24: 15-16.
29. Dhillon, V.S., Shahid, M., and Husain, S.A. 2004. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin. Mol. Cancer 3: 33.
30. Donahue, S.L., Lundberg, R., Saplis, R., and Campbell, C. 2003. Deficient regulation of DNA double-strand break repair in Fanconi anemia fibroblasts. J. Biol. Chem. 278: 29487-29495.
31. Dronkert, M.L. and Kanaar, R. 2001. Repair of DNA interstrand cross-links. Mutat. Res. 486: 217-247.
32. Duckworth-Rysiecki, G. and Taylor, A.M. 1985. Effects of ionizing radiation on cells from Fanconi's anemia patients. Cancer Res. 45: 416-420.
33. Elledge, S.J. and Amon, A. 2002. The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients. Cancer Cell 1: 129-132.
34. Farmer, H., McCabe, N., Lord, C.J., Tutt, A.N., Johnson, D.A., Richardson, T.B., Santarosa, M., Dillon, K.J., Hickson, I., Knights, C., et al. 2005. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921.
35. Ford, D., Easton, D.F., Bishop, D.T., Narod, S.A., and Goldgar, D.E. 1994. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343: 692-695.
36. Freie, B.W., Ciccone, S.L., Li, X., Plett, P.A., Orschell, C.M., Srour, E.F., Hanenberg, H., Schindler, D., Lee, S.H., and Clapp, D.W. 2004. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint. J. Biol. Chem. 279: 50986-50993.
37. Friedberg, E.C., Wagner, R., and Radman, M. 2002. Specialized DNA polymerases, cellular survival, and the genesis of mutations. Science 296: 1627-1630.
38. Friedberg, E.C., Lehmann, A.R., and Fuchs, R.P. 2005. Trading places: How do DNA polymerases switch during translesion DNA synthesis? Mol. Cell 18: 499-505.
39. Garcia-Higuera, I., Kuang, Y., Denham, J., and D'Andrea, A.D. 2000. The Fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. Blood 96: 3224-3230.
40. Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M.S., Timmers, C., Hejna, J., Grompe, M., and D'Andrea, A.D. 2001. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7: 249-262.
41. German, J., Schonberg, S., Caskie, S., Warburton, D., Falk, C., and Ray, J.H. 1987. A test for Fanconi's anemia. Blood 69: 1637-1641.
42. Gordon, S.M. and Buchwald, M. 2003. Fanconi anemia protein complex: Mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood 102: 136-141.
43. Gregory, R.C., Taniguchi, T., and D'Andrea, A.D. 2003. Regulation of the Fanconi anemia pathway by monoubiquitination. Semin. Cancer Biol. 13: 77-82.
44. Gupta, R., Sharma, S., Sommers, J.A., Jin, Z., Cantor, S.B., and Brosh Jr., R.M. 2005. Analysis of the DNA substrate specificity of the human BACH1 helicase associated with breast cancer. J. Biol. Chem. 280: 25450-25460.
45. Hahn, S.A., Greenhalf, B., Ellis, I., Sina-Frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Raeburn, J.A., et al. 2003. BRCA2 germline mutations in familial pancreatic carcinoma. J. Natl. Cancer Inst. 95: 214-221.
46. Helt, C.E., Cliby, W.A., Keng, P.C., Bambara, R.A., and O'Reilly, M.A. 2005. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage. J. Biol. Chem. 280: 1186-1192.
47. Hirano, S., Yamamoto, K., Ishiai, M., Yamazoe, M., Seki, M., Matsushita, N., Ohzeki, M., Yamashita, Y.M., Arakawa, H., Buerstedde, J.M., et al. 2005. Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM. EMBO J. 24: 418-427.
48. +/-) accelerates epithelial tumor formation in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Cancer Res. 65: 85-91.
49. Howlett, N.G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., De Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. 2002. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297: 606-609.
50. Howlett, N.G., Taniguchi, T., Durkin, S.G., D'Andrea, A.D., and Glover, T.W. 2005. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum. Mol. Genet. 14: 693-701.
51. Hussain, S., Wilson, J.B., Medhurst, A.L., Hejna, J., Witt, E., Ananth, S., Davies, A., Masson, J.Y., Moses, R., West, S.C., et al. 2004. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet. 13: 1241-1248.
52. Joenje, H. and Patel, K.J. 2001. The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet. 2: 446-457.
53. Jonnalagadda, V.S., Matsuguchi, T., and Engelward, B.P. 2005. Interstrand cross-link-induced homologous recombination carries an increased risk of deletions and insertions. DNA Repair (Amst.) 4: 594-605.
54. Karow, J.K., Chakraverty, R.K., and Hickson, I.D. 1997. The Bloom's syndrome gene product is a 3′-5′ DNA helicase. J. Biol. Chem. 272: 30611-30614.
55. Kennedy, R.D., Quinn, J.E., Mullan, P.B., Johnston, P.G., and Harkin, D.P. 2004. The role of BRCA1 in the cellular response to chemotherapy. J. Natl. Cancer Inst. 96: 1659-1668.
56. King, M.C., Marks, J.H., and Mandell, J.B. 2003. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302: 643-646.
57. Knudson Jr., A.G. 1971. Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl. Acad. Sci. 68: 820-823.
58. Kobayashi, J., Antoccia, A., Tauchi, H., Matsuura, S., and Komatsu, K. 2004. NBS1 and its functional role in the DNA damage response. DNA Repair (Amst.) 3: 855-861.
59. Komori, K., Fujikane, R., Shinagawa, H., and Ishino, Y. 2002. Novel endonuclease in Archaea cleaving DNA with various branched structure. Genes Genet. Syst. 77: 227-241.
60. Kubbies, M., Schindler, D., Hoehn, H., Schinzel, A., and Rabinovitch, P.S. 1985. Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent edomitosis in Fanconi anemia cells. Am. J. Hum. Genet. 37: 1022-1030.
61. Kupfer, G., Naf, D., Garcia-Higuera, I., Wasik, J., Cheng, A., Yamashita, T., Tipping, A., Morgan, N., Mathew, C.G., and D'Andrea, A.D. 1999. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation. Exp. Hematol. 27: 587-593.
62. Kutler, D.I., Auerbach, A.D., Satagopan, J., Giampietro, P.F., Batish, S.D., Huvos, A.G., Goberdhan, A., Shah, J.P., and Singh, B. 2003a. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch. Otolaryngol. Head Neck Surg. 129: 106-112.
63. Kutler, D.I., Singh, B., Satagopan, J., Batish, S.D., Berwick, M., Giampietro, P.F., Hanenberg, H., and Auerbach, A.D. 2003b. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101: 1249-1256.
64. Kutler, D.I., Wreesmann, V.B., Goberdhan, A., Ben-Porat, L., Satagopan, J., Ngai, I., Huvos, A.G., Giampietro, P., Levran, O., Pujara, K., et al. 2003c. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J. Natl. Cancer Inst. 95: 1718-1721.
65. Lawley, P.D. and Phillips, D.H. 1996. DNA adducts from chemotherapeutic agents. Mutat. Res. 355: 13-40.
66. Levitus, M., Rooimans, M.A., Steltenpool, J., Cool, N.F., Oostra, A.B., Mathew, C.G., Hoatlin, M.E., Waisfisz, Q., Arwert, F., de Winter, J.P., et al. 2004. Heterogeneity in Fanconi anemia: Evidence for 2 new genetic subtypes. Blood 103: 2498-2503.
67. Levitus, M., Waisfisz, Q., Godthelp, B.C., De Vries, Y., Hussain, S., Wiegant, W.W., Elghabzouri-Maghrani, E., Steltenpool, J., Rooimans, M., Pals, G., et al. 2005. The DNA Helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat. Genet. 37: 934-935.
68. Levran, O., Attwooll, C., Henry, R.T., Milton, K.L., Neveling, K., Rio, P., Batish, S.D., Kalb, R., Velleuer, E., Barral, S., et al. 2005. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi Anemia. Nat. Genet. 39: 931-933.
69. Liede, A., Karlan, B.Y., and Narod, S.A. 2004. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: A review of the literature. J. Clin. Oncol. 22: 735-742.
70. Litman, R., Peng, M., Jin, Z., Zhang, F., Zhang, J., Powell, S., Andreassen, P.R., and Cantor, S.B. 2005. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8: 255-265.
71. Liu, Q., Guntuku, S., Cui, X.S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. 2000. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes & Dev. 14: 1448-1459.
72. Liu, T.X., Howlett, N.G., Deng, M., Langenau, D.M., Hsu, K., Rhodes, J., Kanki, J.P., D'Andrea, A.D., and Look, A.T. 2003. Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis. Dev. Cell 5: 903-914.
73. Lomonosov, M., Anand, S., Sangrithi, M., Davies, R., and Venkitaraman, A.R. 2003. Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes & Dev. 17: 3017-3022.
74. Lo Ten Foe, J.R., Rooimans, M.A., Bosnoyan-Collins, L., Alon, N., Wijker, M., Parker, L., Lightfoot, J., Carreau, M., Callen, D.F., Savoia, A., et al. 1996. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat. Genet. 14: 320-323.
75. Marsit, C.J., Liu, M., Nelson, H.H., Posner, M., Suzuki, M., and Kelsey, K.T. 2004. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: Implications for treatment and survival. Oncogene 23: 1000-1004.
76. Meetei, A.R., de Winter, J.P., Medhurst, A.L., Wallisch, M., Waisfisz, Q., van de Vrugt, H.J., Oostra, A.B., Yan, Z., Ling, C., Bishop, C.E., et al. 2003a. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35: 165-170.
77. Meetei, A.R., Sechi, S., Wallisch, M., Yang, D., Young, M.K., Joenje, H., Hoatlin, M.E., and Wang, W. 2003b. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol. 23: 3417-3426.
78. Meetei, A.R., Levitus, M., Xue, Y., Medhurst, A.L., Zwaan, M., Ling, C., Rooimans, M.A., Bier, P., Hoatlin, M., Pals, G., et al. 2004. X-linked inheritance of Fanconi anemia complementation group B. Nat. Genet. 36: 1219-1224.
79. Meetei, A.R., Medhurst, A.L., Ling, C., Xue, Y., Singh, T.R., Bier, P., Steltenpool, J., Stone, S., Dokal, I., Mathew, C.G., et al. 2005. A human ortholog of archael DNA repair protein HEF is defective in Fanconi anemia complementation group M. Nat. Genet. 37: 958-963.
80. Mi, J. and Kupfer, G.M. 2005. The Fanconi anemia core complex associates with chromatin during S phase. Blood 105: 759-766.
81. Miglierina, R., Le Coniat, M., and Berger, R. 1991. A simple diagnostic test for Fanconi anemia by flow cytometry. Anal. Cell. Pathol. 3: 111-118.
82. Mosedale, G., Niedzwiedz, W., Alpi, A., Perrina, F., Pereira-Leal, J., Johnson, M., Langevin, F., Pace, P., and Patel, K.J. 2005. The vertebrate Hef orthologue is a component of the Fanconi anemia tumour suppressor pathway. Nat. Struct. Mol. Biol. 12: 963-971.
83. Moynahan, M.E., Chiu, J.W., Koller, B.H., and Jasin, M. 1999. Brca1 controls homology-directed DNA repair. Mol. Cell 4: 511-518.
84. Moynahan, M.E., Cui, T.Y., and Jasin, M. 2001a. Homologydirected DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res. 61: 4842-4850.
85. Moynahan, M.E., Pierce, A.J., and Jasin, M. 2001b. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell 7: 263-272.
86. Nakanishi, K., Taniguchi, T., Ranganathan, V., New, H.V., Moreau, L.A., Stotsky, M., Mathew, C.G., Kastan, M.B., Weaver, D.T., and D'Andrea, A.D. 2002. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat. Cell. Biol. 4: 913-920.
87. Nakanishi, K., Yang, Y.G., Pierce, A.J., Taniguchi, T., Digweed, M., D'Andrea, A.D., Wang, Z.Q., and Jasin, M. 2005. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl. Acad. Sci. 102: 1110-1115.
88. Narayan, G., Arias-Pulido, H., Nandula, S.V., Basso, K., Sugirtharaj, D.D., Vargas, H., Mansukhani, M., Villella, J., Meyer, L., Schneider, A., et al. 2004. Promoter hypermethylation of FANCF: Disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res. 64: 2994-2997.
89. Niedzwiedz, W., Mosedale, G., Johnson, M., Ong, C.Y., Pace, P., and Patel, K.J. 2004. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 15: 607-620.
90. Nijman, S.M., Huang, T.T., Dirac, A.M., Brummelkamp, T.R., Kerkhoven, R.M., D'Andrea, A.D., and Bernards, R. 2005. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17: 331-339.
91. Okada, T., Sonoda, E., Yamashita, Y.M., Koyoshi, S., Tateishi, S., Yamaizumi, M., Takata, M., Ogawa, O., and Takeda, S. 2002. Involvement of vertebrate polκ in Rad18-independent postreplication repair of UV damage. J. Biol. Chem. 277: 48690-48695.
92. Onclercq-Delic, R., Calsou, P., Delteil, C., Salles, B., Papadopoulo, D., and Amor-Gueret, M. 2003. Possible anti-recombinogenic role of Bloom's syndrome helicase in doublestrand break processing. Nucleic Acids Res. 31: 6272-6282.
93. Orelli, B.J., Logsdon Jr, J.M., and Bishop, D.K. 2001. Nine novel conserved motifs in BRCA1 identified by the chicken orthologue. Oncogene 20: 4433-4438.
94. Orlicky, S., Tang, X., Willems, A., Tyers, M., and Sicheri, F. 2003. Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell 112: 243-256.
95. Pace, P., Johnson, M., Tan, W.M., Mosedale, G., Sng, C., Hoatlin, M., de Winter, J., Joenje, H., Gergely, F., and Patel, K.J. 2002. FANCE: The link between Fanconi anaemia complex assembly and activity. EMBO J. 21: 3414-3423.
96. Papadopoulo, D., Guillouf, C., Mohrenweiser, H., and Moustacchi, E. 1990a. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc. Natl. Acad. Sci. 87: 8383-8387.
97. Papadopoulo, D., Guillouf, C., Porfirio, B., and Moustacchi, E. 1990b. Decreased mutagenicity in Fanconi's anemia lymphoblasts following treatment with photoactivated psoralens. Prog. Clin. Biol. Res. 340A: 241-248.
98. Pichierri, P. and Rosselli, F. 2004. The DNA cross-link-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J. 23: 1178-1187.
99. Pichierri, P., Averbeck, D., and Rosselli, F. 2002. DNA crosslink-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum. Mol. Genet. 11: 2531-2546.
100. Poll, E.H., Arwert, F., Joenje, H., and Wanamarta, A.H. 1985. Differential sensitivity of Fanconi anaemia lymphocytes to the clastogenic action of cis-diamminedichloroplatinum (II) and trans-diamminedichloroplatinum (II). Hum. Genet. 71: 206-210.
101. Prakash, S. and Prakash, L. 2002. Translesion DNA synthesis in eukaryotes: A one- or two-polymerase affair. Genes & Dev. 16: 1872-1883.
102. Quinn, J.E., Kennedy, R.D., Mullan, P.B., Gilmore, P.M., Carty, M., Johnston, P.G., and Harkin, D.P. 2003. BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis. Cancer Res. 63: 6221-6228.
103. Rebbeck, T.R., Lynch, H.T., Neuhausen, S.L., Narod, S.A., Van't Veer, L., Garber, J.E., Evans, G., Isaacs, C., Daly, M.B., Matloff, E., et al. 2002. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med. 346: 1616-1622.
104. Rischewski, J.R., Clausen, H., Leber, V., Niemeyer, C., Ritter, J., Schindler, D., and Schneppenheim, R. 2000. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy. Klin. Padiatr. 212: 174-176.
105. Risinger, M.A. and Groden, J. 2004. Crosslinks and crosstalk: Human cancer syndromes and DNA repair defects. Cancer Cell 6: 539-545.
106. Rodriguez, M., Yu, X., Chen, J., and Songyang, Z. 2003. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. J. Biol. Chem. 278: 52914-52918.
107. Ross, A.L., Simpson, L.J., and Sale, J.E. 2005. Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1. Nucleic Acids Res. 33: 1280-1289.
108. Rothfuss, A. and Grompe, M. 2004. Repair kinetics of genomic interstrand DNA cross-links: Evidence for DNA doublestrand break-dependent activation of the Fanconi anemia/ BRCA pathway. Mol. Cell. Biol. 24: 123-134.
109. Sala-Trepat, M., Rouillard, D., Escarceller, M., Laquerbe, A., Moustacchi, E., and Papadopoulo, D. 2000. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp. Cell. Res. 260: 208-215.
110. Shiloh, Y. 2001. ATM and ATR: Networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11: 71-77.
111. Sridharan, D., Brown, M., Lambert, W.C., McMahon, L.W., and Lambert, M.W. 2003. Nonerythroid αII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links. J. Cell. Sci. 116: 823-835.
112. Strathdee, C.A., Duncan, A.M., and Buchwald, M. 1992a. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat. Genet. 1: 196-198.
113. Strathdee, C.A., Gavish, H., Shannon, W.R., and Buchwald, M. 1992b. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356: 763-767. [Published erratum appears in Nature 1992 358: 434]
114. Taniguchi, T. and D'Andrea, A.D. 2002. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood 100: 2457-2462.
115. Taniguchi, T., Garcia-Higuera, I., Andreassen, P.R., Gregory, R.C., Grompe, M., and D'Andrea, A.D. 2002a. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100: 2414-2420.
116. Taniguchi, T., Garcia-Higuera, I., Xu, B., Andreassen, P.R., Gregory, R.C., Kim, S.T., Lane, W.S., Kastan, M.B., and D'Andrea, A.D. 2002b. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109: 459-472.
117. Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S.V., Mathew, C.G., Joenje, H., Mok, S.C., and D'Andrea, A.D. 2003. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat. Med. 9: 568-574.
118. Timmers, C., Taniguchi, T., Hejna, J., Reifsteck, C., Lucas, L., Bruun, D., Thayer, M., Cox, B., Olson, S., D'Andrea, A.D., et al. 2001. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell 7: 241-248.
119. Tischkowitz, M.D., Morgan, N.V., Grimwade, D., Eddy, C., Ball, S., Vorechovsky, I., Langabeer, S., Stoger, R., Hodgson, S.V., and Mathew, C.G. 2004. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Leukemia 18: 420-425.
120. Tutt, A., Bertwistle, D., Valentine, J., Gabriel, A., Swift, S., Ross, G., Griffin, C., Thacker, J., and Ashworth, A. 2001. Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J. 20: 4704-4716.
121. Vandenberg, C.J., Gergely, F., Ong, C.Y., Pace, P., Mallery, D.L., Hiom, K., and Patel, K.J. 2003. BRCA1-independent ubiquitination of FANCD2. Mol. Cell 12: 247-254.
122. van der Heijden, M.S., Brody, J.R., Gallmeier, E., Cunningham, S.C., Dezentje, D.A., Shen, D., Hruban, R.H., and Kern, S.E. 2004. Functional defects in the Fanconi anemia pathway in pancreatic cancer cells. Am. J. Pathol. 165: 651-657.
123. Wang, X., Andreassen, P.R., and D'Andrea, A.D. 2004. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol. 24: 5850-5862.
124. Wilkinson, K.D. 2000. Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasome. Semin. Cell. Dev. Biol. 11: 141-148.
125. Wu, L. and Hickson, I.D. 2002. The Bloom's syndrome helicase stimulates the activity of human topoisomerase IIIα. Nucleic Acids Res. 30: 4823-4829.
126. Wyman, C., Ristic, D., and Kanaar, R. 2004. Homologous recombination-mediated double-strand break repair. DNA Repair (Amst.) 3: 827-833.
127. Xia, F. and Powell, S.N. 2002. The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer. Semin. Radiat. Oncol. 12: 296-304.
128. Xie, Y., de Winter, J.P., Waisfisz, Q., Nieuwint, A.W., Scheper, R.J., Arwert, F., Hoatlin, M.E., Ossenkoppele, G.J., Schuurhuis, G.J., and Joenje, H. 2000. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells. Br. J. Haematol. 111: 1057-1064.
129. Yamamoto, K., Ishiai, M., Matsushita, N., Arakawa, H., Lamerdin, J.E., Buerstedde, J.M., Tanimoto, M., Harada, M., Thompson, L.H., and Takata, M. 2003. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol. Cell. Biol. 23: 5421-5430.
130. Yamashita, Y.M., Okada, T., Matsusaka, T., Sonoda, E., Zhao, G.Y., Araki, K., Tateishi, S., Yamaizumi, M., and Takeda, S. 2002. RAD18 and RAD54 cooperatively contribute to maintenance of genomic stability in vertebrate cells. EMBO J. 21: 5558-5566.
131. Yang, Y.G., Herceg, Z., Nakanishi, K., Demuth, I., Piccoli, C., Michelon, J., Hildebrand, G., Jasin, M., Digweed, M., and Wang, Z.Q. 2005. The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells. Carcinogenesis 26: 1731-1740.
132. Yu, S.L., Johnson, R.E., Prakash, S., and Prakash, L. 2001. Requirement of DNA polymerase η for error-free bypass of UV-induced CC and TC photoproducts. Mol. Cell. Biol. 21: 185-188.
133. Yu, X., Chini, C.C., He, M., Mer, G., and Chen, J. 2003. The BRCT domain is a phospho-protein binding domain. Science 302: 639-642.
134. Zhong, Q., Chen, C.F., Li, S., Chen, Y., Wang, C.C., Xiao, J., Chen, P.L., Sharp, Z.D., and Lee, W.H. 1999. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285: 747-750.
135. Zou, L. and Elledge, S.J. 2003. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300: 1542-1548.